You are here
New drugs for the treatment of leishmaniasis
Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43AI058549-01A1
Agency Tracking Number: AI058549
Amount:
$100,000.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
N/A
Solicitation Number:
PHS2004-2
Timeline
Solicitation Year:
2004
Award Year:
2004
Award Start Date (Proposal Award Date):
N/A
Award End Date (Contract End Date):
N/A
Small Business Information
MYCOLOGICS, INC.
12635 E MONTVIEW BLVD, STE 131
AURORA, CO
80010
United States
DUNS:
N/A
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: CLAUDE Selitrennikoff
Phone: (720) 859-4190
Email: CLAUDE.SELITRENNIKOFF@UCHSC.EDU
Phone: (720) 859-4190
Email: CLAUDE.SELITRENNIKOFF@UCHSC.EDU
Business Contact
Name: CLAUDE SELITRENNIKOFF
Phone: (720) 859-4190
Email: CLAUDE.SELITRENNIKOFF@UCHSC.EDU
Phone: (720) 859-4190
Email: CLAUDE.SELITRENNIKOFF@UCHSC.EDU
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Leishmania are typanosomatid protozoans that are transmitted by phlebotomine sand flies causing leishmaniasis. Leishmaniasis is a zoonosis and affects 12 million people in 88 countries, of which 72 are considered devel
* Information listed above is at the time of submission. *
